Li Hua Zheng
Fondateur chez AnHeart Therapeutics (Hangzhou) Co., Ltd.
Postes actifs de Li Hua Zheng
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
AnHeart Therapeutics (Hangzhou) Co., Ltd.
 AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Directeur/Membre du Conseil | 27/11/2018 | - |
| Fondateur | 27/11/2018 | - | |
| Corporate Officer/Principal | 27/11/2018 | - | |
| Anbio, Inc. | Directeur/Membre du Conseil | 01/12/2017 | - |
| Fondateur | 01/12/2017 | - | |
| Zheng & Karg LLP | Corporate Officer/Principal | 01/01/2018 | - |
Historique de carrière de Li Hua Zheng
Anciens postes connus de Li Hua Zheng
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Liu, Zheng, Chen & Hoffman LLP | Corporate Officer/Principal | 01/10/2015 | 01/12/2017 |
| UCOMMUNE INTERNATIONAL LTD | Directeur/Membre du Conseil | 01/12/2018 | - |
| Independent Dir/Board Member | 01/12/2018 | - |
Formation de Li Hua Zheng
| Fordham University School of Law | Graduate Degree |
| Baylor College of Medicine | Doctorate Degree |
| Fudan University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Chine | 3 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Graduate Degree | 2 |
Sectorielle
| Consumer Services | 4 |
| Finance | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Orisun Acquisition Corp.
 Orisun Acquisition Corp. Financial ConglomeratesFinance Orisun Acquisition Corp. is a blank check company, which engages in the provision of merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination, with one or more target businesses. The company was founded on October 22, 2018 and is headquartered in New York, NY. | Finance |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Commercial Services |
| Anbio, Inc. | |
| Zheng & Karg LLP | |
| Liu, Zheng, Chen & Hoffman LLP |
- Bourse
- Insiders
- Li Hua Zheng
- Expérience
